A Phase IB Study of Pembrolizumab in Combination With Pemetrexed and Oxaliplatin in Patients With Chemo-Refractory Metastatic Colorectal Cancer
Phase of Trial: Phase I
Latest Information Update: 13 Nov 2019
Price : $35 *
At a glance
- Drugs Oxaliplatin (Primary) ; Pembrolizumab (Primary) ; Pemetrexed (Primary) ; Cobalamin; Dexamethasone; Folic acid
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 31 Jul 2019 Status changed from not yet recruiting to recruiting.
- 08 Mar 2019 Planned initiation date changed from 1 Aug 2018 to 1 Apr 2019.
- 21 Aug 2018 New trial record